NYSE •
Healthcare •
Medical Devices •
Quote as of 08/10/2026 16:00
Company Profile
IndustryMedical Devices
SectorHealthcare
ExchangeNYSE
Market Capitalization342.14 mln
Float67.99 mln
Earnings Date08/18/2026
Piotroski F-Score
1
/ 9
Very weak
1-Year Forecast
12.79
Transformational upside
Relative Strength
77
/ 100
Strongly outperforming
Debt / Equity
0.01
Debt-free
ROE
-41.25
Deeply negative
Dividend Yield
0.00%
No dividend
Business Description
Perspective Therapeutics is a US-based oncology company focused on developing targeted alpha therapies that deliver radiation directly to cancer cells with high precision. Its pipeline includes treatments for neuroendocrine tumors, metastatic melanoma, and prostate cancer, with several candidates currently in clinical trials. The company also has a research collaboration with Bristol Myers Squibb exploring combination therapy approaches for melanoma patients. Founded in 2004 and headquartered in Seattle, Washington, it was previously known as Isoray Inc. before rebranding in 2022.
